Summary: Two immuno-assay methods (RIA and ELISA) have been developed for the accurate and sensitive measurement of cotinine in human body fluids (serum, saliva).
The comparative nalysis of cotinine in 96 human sera revealed a good c rrelation between the two methods (r = 0.97) and a reliable discrimination between the populations of non-smokers and smokers. As usual, the ELISA is more rapid (4h 30min) than the RIA (longer than 48h). ELISA is proposed for use in the epidemiological investigation of the human tobacco risk. on Cotinine elimination in different body fluids varies Cotinine is the major metabolite of nicotine. In hu-significantly (2) . In adult non-smokers, the serum mans, 70% of nicotine is met bolized (oxidized) to concentration of cotinine is 1.5 μg/l J and concentracotinine, 4% is oxidized differently, 9% is excreted tions in saliva and urine are 1.7 and 5.0 μ §/1, respecunchanged in urine and the metabolic fate of the tively. In smokers, these values increase about 180 remaining 17% is still unknown (1) .
fold in plasma and in saliva, and 280 fold in urine (3) . Serum cotinine is considered to be a useful bio-: logical indicator of environmental-tobacco-smoke ex-! tinine level is 0.20 ± 0.44 μ^Ι and 1.87 ± 2.38 respectively. This difference was greater when children were exposed to tobacco (4) . The aim of this work was to develop a sensitive radioimmuno-assay (RIA) and a one-site enzymometric assay (ELISA) for the quantification of cotinine. The most convenient of these methods for routine work will be used for epidemiological studies, which require reliable discrimination between active smokers, passive smokers and non-smokers.
Materials and Methods

Reagents
All reagents were of analytical grade. 7ra/7,s-4'-carboxycotinine and sheep cotinine antiserum prepared using /ra/7i-4'-carboxycotinine conjugated to keyhole limpet haemocyanin s immunogen (cross-reaction at 50% displacement was 100% for cotinine and less than 1% for nicotine) were obtained from International Laboratory Services (London, OB). 3 H-labelled cotinine (specific activity 57.8 TBq/mol) was obtained from Amersham (Aylesburg, GB). Charcoal-dextran was from C.E.A. (Gif/Yvette, F), Gelatin-Bacto from Difco (Detroit, Mi, USA), Casein vitamin-free from Serva (Heidelberg, D), and Protein A sepharose from Pharmacia (Uppsala, S). Biotin amidocaproate-N-hydroxysuccinimide ester, extravidin peroxidase conjugate, o-phenylenediamine dihydrochloride, hydrogen peroxide 30% (300 g/kg), polylysine, (-)cotinine, and l-ethyl-3-(3-dimethylaminopropyl) carbodiimide were from Sigma (St. Louis, Mo. USA). All other chemicals were from Merck (Darmstadt, D). Scintran, cocktail EX was purchased from BDH chemicals Ltd (Poole, GB). EI A 96 wells microtitre plates with high binding capacity were from Costar (Cambridge, Ma, USA).
Human specimens
Blood from 96 supposed healthy subjects attending the Centre for Preventive Medicine (Vandoeuvre-Nancy, F) for health screening was collected in tubes containing clot activator (from Becton Dickinson, Mountain View, Ca, USA) and centrifuged at 1200g for 10 minutes. Serum was then frozen at -20 °C until analysis.
Whole mixed saliva was collected (between 8.00 and 9.00 a. m.) from the same population using salivette Systems (Sarstedt, N mbrecht, D). After centrifugation at 1200g for 10 minutes the clear saliva was analysed or frozen at -20 °C.
Radio-immuno-assay (RIA)
The assay was performed in glass tubes (10x75 mm). Tris buffer (200 μΐ) pH 7.4 (Tris-HCl 10 mmol/1 containing 150 mmol/1 of NaCl and l g of gelatin per litre) was added to 100 μΐ of [ 3 H]cotinine in Tris buffer (Ag*), 100 μΐ of Standard or sample (Ag), and 100 μΐ of antiserum in Tris buffer (Ab), then incubated ovcrnight at 4 °C. A Suspension (500 μΐ) of charcoaldextran (2.2 g/l in Tris buffer) was added with stirring, and the tubes were incubated at 4°C for 10 min for adsorption of the free antigen. After cenlrifugation at 3000 g for 15 min at 4 °C, 500 μΐ of supernatant were mixed with 10ml of scintillation cocktail and counted in a Beckman counter (LS 1801).
The amounts of Ag in physiological fluids were determined using a Standard curve.
One site enzymometric assay (ELISA)
Preparation of specific reagents
Anti-cotinine imniunoglobulins G were separated on a column of Protein A Sepharose. After overnight dialysis against 100 mmol/1 sodium bicarbonate pH 8.0 at 4 °C, IgG were concentrated using ultrafiltration (l g/l) and stored at ^20°C until use.
Biotinylation of ahti-c tinirie IgG was performed according to Costello et al. (8) . Biotin conjugate was stored at -20 °C in glycerol (for fluorescence micfoscopy) containing 0.2 g sodium azide per litre. The final volume fraction of glycerol was 0.50. The optimal dilution was determined for each batch, Cotinine-polylysine conjugate (2 g/l) was prepared according to the procedure described by Bjercke et al. (9) and aliquots were stored at -20 °C until use.
ELISA protocol
The procedure described by Bjercke et al. (9) was modified. Microtitre plates were cqated with cotinine^polylysine conjugate by incubating at 4°C overnight. The conjugate was dil ted 1000-fold in phosphate buffer, 3 mmol/1, pH 6.35, and 100 μΐ of this solution were added to each well. After coating, the plates were washed three times with "casein buffer" pH 7.6, containing 10 mmol Tris-HCl, 10 mmol sodium chloride, 10 mmol EDTA and 2 g casein per litre. The unoccupied sites were blocked by incubating the plates with "casein buffer" for l h at room temperature; the plates were-then washed three times with the same buffer and used immediately.
The Standard curve was obtained by adding 50 μΐ of serial dilutions of cotinine made up in blank serum (pool of sera collected from 5 non-smokers dil ted l: 5 in "Tris b ffer" for RIA and in "casein buffer" for ELISA) and 50 μΐ of anticotinine conjugate (dil ted l: 100) in the same buffer. The assay plate was incubated for 2 h at 37 °C in a wet chamber. The maximum binding point (B 0 ) was determined by incubating 50 μΐ of anti-cotinine conjugate with 50 μΐ of "casein buffer". Control wells contained all reagents except anti-cotinine conjugate. After incubation, the samples were removed and the plate washed three times with "casein buffer".
A solution containing 0.66 mg/1 of horse-radish peroxidaser conjugated extravidin (100 μΐ) was dispensed into each well and the plate incubated for l h at room temperature. 
Results
Optimization of the assay procedures
RIA: Determination of the appropriate dilutions for antibody (Ab) and labelled antigen (Ag*)
The dilution of Ab able to bind 50% of a known amount of Ag* was chosen. Two dilutions of Ag* were tested (20000 or 10000 counts/min). The antibody dilution curves were constructed by adding 300 μΐ of Tris buffer, pH 7.4 to 100 μΐ of Ag* and 100 μΐ of Ab dilutions (l: 5, l: 10, l: 50, l: 100, l: 200 and l: 500) in the same buffer. All subsequent procedures were those described in the "radio-immuno-assay" section. The best dilution of Ab was l: 150, using the Ag* dilution giving 10000 counts/min. For each new batch of Ab the best dilution should be evaluated.
ELISA: Optimization ofthe fest
Various dilutions of cotinine-polylysine conjugate were tested. The best coating was obtained with l: 1000 dilution. The optimal dilution of the biotinylated antibodies was obtained with l: 100 dilution in "casein buffer". The best results were obtained with extravidin-peroxidase conjugate diluted to l: 3000 (0.66 mg/1) in the same buffer. The incubation conditions were chosen s 16h at 4 °C. The sensitivity was highest for low concentrations of cotinine (< 5 μg/l), the slope of the curve being steeper in this r nge.
Incubation conditions
RIA
ELISA
Several incubation temperatures and times were also tested to determine the optimal conditions, which were estimated from the minimal signal/noise ratio and within-run variability. The best detection limit (0.1 μ §/1) was obtained after 2 h incubation at 37 °C . in a wet chamber. Figure 2 shows the Standard curve obtained in buffer. It covered the r nge of cotinine content found in nonsmokers, passive smokers and active smokers (3). It was very reproducible, showing day to day coefficients of Variation of 2.9% for 50 μ §/1 and 3.7% for 500 ( n = 10). The detection limit of the test was 0.1
Optimization of the Standard curves
RIA
800-
Standard curves made up in physiological fluids, i. e. serum and saliva, gave a similar slope and dynamic r nge.
ELISA Figure 2 shows the Standard curve of cotinine made in blank serum. This Standard curve was reproducible when measured on 10 different days, the coefficients of Variation being 5.5% for 50 μg/l and 7.7% for 500 μg/l. The detection limit was similar to that of the RIA.
Precision
The repeatability of the methods was assayed by measuring the serum cotinine level 30 times consecutively in -unique series, while the reproducibility was determined on 10 different days. The within-run and day to day coefficients of Variation were less than 8.5% for RIA and less than 6% for ELISA (r nge 200 -500 μg/l). These Variation coefficients were greater for the low values found in non-smokers: 50% for 0.1 μ §/1 (RIA) and less than 20% for 20 μ( ELISA).
Linearity Sera of smokers were tested ( fig. 3 ). Assays were performed by RIA and ELISA, with and without dilutions (1:2, 1:4, 1:10, 1:50) in blank serum. Good linearity was observed for ELISA. However, RIA was non-linear for concentrations higher than 400 μ §/1. In order to correlate the results obtained by both methods the samples to be analysed were diluted (l : 2) in blank serum.
Recovery
Sera were spiked with cotinine and quantitated in order to calculate the analytical recovery. The mean analytical recovery tested for concentrations between 50 and 500 μ §/1 was 98% (r nge 96-104) for RIA and 105% (r nge 103-107) for ELISA, which was acceptable for both methods.
Stability in serum
A single freezing-thawing cycle (-20°C/room temperature, performed over 48 h) did not give any Variation in serum cotinine level. Additional cycles produced decreases of serum cotinine (-10 to -33%) and must be avoided. Sample assays (sera) The usual values for smokers and non-smokers are indicated in table l. 
Discussion
In order to easily discriminate non-smokers from smokers it is necessary to increase the detection limit and the sensitivity of cotinine measurements, and many modifications have been attempted.
Radio-immuno-assays for the measurement of cotinine are classically modifications of the Langone technique (6) using [ 3 H]cotinine and polyclonal antiserum. In these methods a second antibody was used for separating the complexes, and this Step usually required 16 h. Matsukura et al. (10) and Waldei al. (11) proposed ammonium sulphate precipitation and chloroform extraction for the determination of the cotinine level in urine. Many modifications were tested and the lowest detection limit was 0.37 μg/l of cotinine by radio-immuno-assay and 0.2 μg/l by gas-chromatography using nitrogen-selective detection (4, 7, (12) (13) (14) . Using 125 I labelling and incubating Standard or plasma samples with the antiserum for l h or for 24 h (non-equilibrium and equilibrium, respectively), a detection limit of 10 μg/l was attained. The comparison (tab. 2) of this modified RIA with that previously described shows that our method gives a better detection limit (0.1 μg/l) than all other published techniques. Surprisingly, linearity is maintained only up to 400 μ §/1. This pseudo-hook effect is rare in competitive techniques. It may be related to partial release of adsorbed labelled antigen in the presence of high concentrations of cotinine (16) . A previous dilution of the sample avoids this effect and allows reliable correlation of RIA and ELISA. The proposed ELISA does not use commercially available reagents but i t has the ad van tage of being more rapid than RIA. The detection limit was similar to RIA (0.1 μg/l). The I 50 values in the respective methods were determined ( fig. 2) . With the RIA, 10 ng of cotinine gave 50% Inhibition, whereas 340 ng of cotinine were required with ELISA. Using monoclonal antibodies ELISA assays are claimed to be 5 -10 times more sensitive (9) . The use of ELISA avoids technical precautions, expensive reagents and a long working time. ELISA is preferable for epidemiological investigation of the risks due to tobacco smoking.
